Effects of short‐term treatment with vibegron for refractory nocturnal enuresis.

  • Published In: Pediatrics International, 2023, v. 65, n. 1. P. 1 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Uchihara, Yoshinori; Yamashita, Sumie; Watanabe, Hiroki; Hata, Daisuke; Hata, Atsuko 3 of 3

Abstract

Background: Long‐term nocturnal enuresis treatment leads to stress and lowered self‐esteem for children and their parents. This study evaluated the short‐term effectiveness and safety of vibegron (50 mg) for children with refractory nocturnal enuresis. Methods: A retrospective cohort study of children with therapy‐resistant enuresis was conducted using data for July to December 2019. Enuresis frequency was recorded during 30 days before and after additional vibegron administration with prior treatment. We assessed the treatment effectiveness based on enuresis frequencies between before and after treatment with vibegron 50 mg. Statistical evaluation was performed using a paired t‐test. Results: Among 29 children receiving vibegron, 14 (48.3%) exhibited a partial or complete response to the drug. Enuresis frequencies (mean ± standard deviation [SD]) were, respectively, 15.8 ± 9.2 and 9.5 ± 9.6 before and after treatment with vibegron during the observed 30 days. A statistically significant reduction in enuresis frequency was found (p < 0.001). Moreover, maximum mean±SD morning urine of 200 ± 62.9 mL before treatment with vibegron changed to 232 ± 76.6 mL after treatment. A significant increase in voiding volume in the early morning was found (p < 0.05). No drug‐related severe adverse event was found. Conclusion: Short‐term treatment with vibegron is safe and effective for children with refractory enuresis. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Pediatrics International. 2023/01, Vol. 65, Issue 1, p1
  • Document Type:Article
  • Subject Area:Complementary and Alternative Medicine
  • Publication Date:2023
  • ISSN:1328-8067
  • DOI:10.1111/ped.15464
  • Accession Number:174473685
  • Copyright Statement:Copyright of Pediatrics International is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.